scholarly article | Q13442814 |
P50 | author | Rene E Toes | Q42494390 |
P2093 | author name string | Shixuan Wang | |
Jerry Y Niederkorn | |||
Martine J Jager | |||
Zita F H M Boonman | |||
Hao-Chuan Li | |||
YuGuang He | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 2789-2796 | |
P577 | publication date | 2003-09-01 | |
P1433 | published in | Journal of Immunology | Q3521441 |
P1476 | title | Role of TRAIL and IFN-gamma in CD4+ T cell-dependent tumor rejection in the anterior chamber of the eye | |
P478 | volume | 171 |
Q42183991 | Abrogating TNF-α expression prevents bystander destruction of normal tissues during iNOS-mediated elimination of intraocular tumors |
Q81459070 | CD4+ T-cell-dependent tumour rejection in an immune-privileged environment requires macrophages |
Q35153266 | CTL Induction of Tumoricidal Nitric Oxide Production by Intratumoral Macrophages Is Critical for Tumor Elimination |
Q35848101 | Chimeric NK-receptor-bearing T cells mediate antitumor immunotherapy. |
Q37905546 | Cornea: Window to Ocular Immunology |
Q34325061 | Corneal transplantation and immune privilege |
Q40230085 | Development of autologous cytotoxic CD4+ T clones in a human model of B-cell non-Hodgkin follicular lymphoma |
Q40086525 | Fas Ligand-mediated cytotoxicity of CD4+ T cells during chronic retrovirus infection. |
Q36024156 | Gamma c cytokines condition the progressive differentiation of CD4+ T cells |
Q39835934 | Genetically engineered T cells expressing a HER2-specific chimeric receptor mediate antigen-specific tumor regression |
Q41780299 | Good news-bad news: the Yin and Yang of immune privilege in the eye. |
Q35269684 | IL-17-dependent, IFN-gamma-independent tumor rejection is mediated by cytotoxic T lymphocytes and occurs at extraocular sites, but is excluded from the eye. |
Q37521988 | Immune cell-mediated liver injury |
Q37535138 | Immune escape mechanisms of intraocular tumors |
Q36100283 | Immunology of intraocular tumors |
Q36285926 | Influence of CD8+ T regulatory cells on intraocular tumor development |
Q37724789 | Influence of immune privilege on ocular tumor development |
Q30375264 | Natural Killer T Cells Contribute to Neutrophil Recruitment and Ocular Tissue Damage in a Model of Intraocular Tumor Rejection |
Q42200330 | Ocular immune privilege and ocular melanoma: parallel universes or immunological plagiarism? |
Q36426813 | See no evil, hear no evil, do no evil: the lessons of immune privilege |
Q34646470 | Splenectomy promotes indirect elimination of intraocular tumors by CD8+ T cells that is associated with IFNγ- and Fas/FasL-dependent activation of intratumoral macrophages |
Q44786845 | TNF-related apoptosis-inducing ligand is involved in neutropenia of systemic lupus erythematosus |
Q57078133 | TRAIL-induced cell death cooperates with IFN-γ activation in the graft-versus-tumor effect against colon tumors |
Q28073631 | The Kynurenine Pathway Is a Double-Edged Sword in Immune-Privileged Sites and in Cancer: Implications for Immunotherapy |
Q24672443 | p53-independent endoplasmic reticulum stress-mediated cytotoxicity of a Newcastle disease virus strain in tumor cell lines |
Search more.